Valuation: Organoidsciences Ltd.

Market Cap 41.69B 30.19M 26.29M 24.89M 22.61M 42.24M 2.89B 42.45M 296M 115M 1.47B 113M 111M 4.7B P/E 2024 *
-
P/E 2025 -15.2x
Enterprise Value 30.13B 21.82M 19M 17.98M 16.34M 30.53M 2.09B 30.68M 214M 82.83M 1.06B 81.96M 80.13M 3.4B EV / Sales 2024 *
-
EV / Sales 2025 99.9x
Free-Float
57.27%
Yield 2024 *
-
Yield 2025 -
1 day-0.16%
1 week-4.09%
Current month-9.31%
1 month-23.09%
3 months-47.82%
6 months-76.38%
Current year-83.47%
1 week 6,100
Extreme 6100
6,650
1 month 6,100
Extreme 6100
8,580
Current year 6,070
Extreme 6070
39,200
1 year 6,070
Extreme 6070
48,500
3 years 6,070
Extreme 6070
52,000
5 years 6,070
Extreme 6070
52,000
10 years 6,070
Extreme 6070
52,000
Manager TitleAgeSince
Chief Executive Officer 62 2026-01-01
Chief Executive Officer 46 -
Chief Tech/Sci/R&D Officer 41 -
Director TitleAgeSince
Director/Board Member 46 -
Director/Board Member 41 -
Director/Board Member - 2025-03-26
Date Insider Type Main position Quantity % Market Cap. Importance
5/14/25 Others

Chief Executive Officer

1,670,000 -
5/14/25 Others 30,000 --
Change 5-day change 1-year change 3-year change Capi.($)
-0.16%-4.09%-83.34% - 30.52M
+1.23%+1.30%-0.69%+9.57% 45.91B
+0.23%+4.72%+44.32%+27.27% 44.25B
+0.52%-3.15%+349.53%+520.09% 41.99B
+1.55%+3.41%+6.40%+76.45% 39.58B
+1.75%-1.53%+12.22%+41.11% 31.08B
-0.20%+5.49%+23.57%+119.72% 17.21B
-3.49%-8.49% - - 16.27B
+2.92%+8.40%+22.46%+38.87% 14.96B
-2.45%+2.41%-3.16%-35.16% 13.42B
Average +0.19%+0.90%+41.26%+99.74% 26.47B
Weighted average by Cap. +0.58%+0.68%+72.20%+120.61%

Financials

2024 2025
Net sales 1.95B 1.41M 1.23M 1.17M 1.06M 1.98M 135M 1.99M 13.89M 5.37M 68.85M 5.31M 5.2M 220M 2.41B 1.74M 1.52M 1.44M 1.31M 2.44M 167M 2.45M 17.11M 6.62M 84.82M 6.55M 6.4M 272M
Net income -11.25B -8.14M -7.09M -6.71M -6.1M -11.4M -780M -11.45M -79.97M -30.92M -396M -30.6M -29.91M -1.27B -15.37B -11.13M -9.69M -9.17M -8.34M -15.57M -1.07B -15.65M -109M -42.25M -542M -41.81M -40.88M -1.73B
Net Debt -8.11B -5.87M -5.11M -4.84M -4.4M -8.21M -562M -8.26M -57.64M -22.29M -286M -22.05M -21.56M -915M -11.56B -8.37M -7.29M -6.9M -6.27M -11.72M -802M -11.77M -82.21M -31.79M -408M -31.45M -30.75M -1.3B
Logo Organoidsciences Ltd.
OrganoidSciences Ltd is a Korea-based company primarily engaged in the development of regenerative therapies and provision of new material evaluation solutions. The Company primarily provides an organoid-based new material evaluation solution under the name of ODISEI to predict the effects of various new materials such as new drugs, foods and cosmetics when applied to the human body. In addition, the Company develops organoid-based regenerative therapies that directly regenerate tissues by engrafting on damaged areas. The Company is also engaged in the sale of intestinal organoid therapeutics, salivary gland organoid regenerative therapeutics, and other research reagents.
Employees
-
Date Price Change Volume
26-09-17 ₩6,330.00 -0.16% 18,622
26-09-16 ₩6,340.00 +1.12% 17,011
26-09-15 ₩6,270.00 -0.79% 16,645
26-09-14 ₩6,320.00 -4.96% 22,767
26-09-11 ₩6,650.00 0.00% 11,701
  1. Stock Market
  2. Stocks
  3. A476040 Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!